AI Science Tracker
EN

Stemness-based gastric cancer classification by machine learning for precision diagnosis and treatment of gastric cancer.

Fudan University Shanghai Cancer Center · 30 Oct 2025 · medicine

Discovery

Stemness-based gastric cancer classification by machine learning for precision diagnosis and treatment of gastric cancer.

Source check: Source checked. Not independent scientific confirmation.

Finding: OCLR stemness scores and consensus clustering in 389 TCGA gastric cancers defined two subtypes; a 12-gene ML model was checked on an external cohort. Predicted immunotherapy/chemotherapy differences are in-silico and not measured treatment responses. The result is reported in Journal of Gastrointestinal Oncology. The study does not establish generalization beyond its reported setting or prospective real-world benefit.

Technology: OCLR stemness scores and consensus clustering in 389 TCGA gastric cancers defined two subtypes

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
OCLR stemness scores and consensus clustering in 389 TCGA gastric cancers defined two subtypes
Test and result
OCLR stemness scores and consensus clustering in 389 TCGA gastric cancers defined two subtypes; a 12-gene ML model was checked on an external cohort. Predicted immunotherapy/chemotherapy differences are in-silico and not measured treatment responses.
Limitation / still unknown
Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12598432/ · https://europepmc.org/article/MED/41220758

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.